Clinical features of autoimmune hepatitis and comparison of two diagnostic criteria in Korea: A nationwide, multicenter study

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue 1, 2013, Pages 128-134

  Kim, Bo Hyun ^a,r,s   Kim, Yoon Jun ^b,r,s   Jeong, Sook Hyang ^b,r   Tak, Won Young ^e,r   Ahn, Sang Hoon ^c,r   Lee, Youn Jae ^f,r   Jung, Eun Uk ^f,r   Lee, Jung Il ^g,r   Yeon, Jong Eun ^d,r   Hwang, Jae Seok ^h,r   Um, Soon Ho ^d,r   Seo, Yeon Seok ^d,r   Kim, Young Seok ^i,r   Song, Byung Cheol ^j,r   Kim, Ju Hyun ^k,r   Jung, Young Kul ^k,r   Park, Choong Kee ^l,r   Kim, Kyung Ah ^f,r   Min, Hyun Ju ^m,r   Cho, Eun Young ^n,r   Lee, Eom Seok ^o,r   Kwon, So Young ^p,r   Chae, Hee Bok ^q,r   Kim, Dong Joon ^l,r   Shin, Su Rin ^l,r   more..

^a Bundang Jesaeng Hospital   (South Korea)

^b National Cancer Center   (South Korea)

^c Seoul National University   (South Korea)

^d Kyungpook National University   (South Korea)

^e Yonsei University   (South Korea)

^f Inje University   (South Korea)

^g Inha University   (South Korea)

^h Korea University   (South Korea)

ⁱ Keimyung University   (South Korea)

^j Soonchunhyang University   (South Korea)

^k Jeju National University   (South Korea)

^l Gachon University   (South Korea)

^m Hallym University   (South Korea)

ⁿ Gyeongsang National University   (South Korea)

^o Wonkwang University   (South Korea)

^p Chungnam National University   (South Korea)

^q Konkuk University   (South Korea)

^r Chungbuk National University   (South Korea)

^s Korean Autoimmune Liver Disease Study Group   (South Korea)

more..

Author keywords

Autoimmune hepatitis; Diagnosis; Diagnostic criteria; Treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; BILIRUBIN; CORTICOSTEROID; GLOBULIN; HEPATITIS B SURFACE ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; IMMUNOGLOBULIN G; MICROSOME ANTIBODY; SMOOTH MUSCLE ANTIBODY;

ADULT; ADULT ONSET STILL DISEASE; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; AUTOIMMUNE HEPATITIS; CELL INFILTRATION; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DECOMPENSATED LIVER CIRRHOSIS; FEMALE; GRAVES DISEASE; HEMOLYTIC ANEMIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KOREA; LIVER BIOPSY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; PLASMA CELL; PREDICTIVE VALUE; PRIORITY JOURNAL; RAYNAUD PHENOMENON; REMISSION; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; TREATMENT FAILURE; TREATMENT RESPONSE; ULCERATIVE COLITIS;

EID: 84871663788     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2012.07292.x     Document Type: Article

References (34)

1. Lee YM, Teo EK, Ng TM, Khor C, Fock KM. Autoimmune hepatitis in Singapore: a rare syndrome affecting middle-aged women. J. Gastroenterol. Hepatol. 2001; 16: 1384-1389.
2. Hurlburt KJ, McMahon BJ, Deubner H, Hsu-Trawinski B, Williams JL, Kowdley KV. Prevalence of autoimmune liver disease in Alaska Natives. Am. J. Gastroenterol. 2002; 97: 2402-2407.
3. Ngu JH, Bechly K, Chapman BA etal. Population-based epidemiology study of autoimmune hepatitis: a disease of older women? J. Gastroenterol. Hepatol. 2010; 25: 1681-1686.
4. Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand. J. Gastroenterol. 1998; 33: 99-103.
5. Werner M, Prytz H, Ohlsson B etal. Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study. Scand. J. Gastroenterol. 2008; 43: 1232-1240.
6. Jalihal A, Telisinghe PU, Chong VH. Profiles of autoimmune hepatitis in Brunei Darussalam. Hepatobiliary Pancreat. Dis. Int. 2009; 8: 602-607.
7. Granito A, Muratori L, Pappas G etal. Clinical features of type 1 autoimmune hepatitis in elderly Italian patients. Aliment. Pharmacol. Ther. 2005; 21: 1273-1277.
8. Lim KN, Casanova RL, Boyer TD, Bruno CJ. Autoimmune hepatitis in African Americans: presenting features and response to therapy. Am. J. Gastroenterol. 2001; 96: 3390-3394.
9. Wong RJ, Gish R, Frederick T, Bzowej N, Frenette C. The Impact of race/ethnicity on the clinical epidemiology of autoimmune hepatitis. J. Clin. Gastroenterol. 2012; 46: 155-161.
10. Toda G, Zeniya M, Watanabe F etal. Present status of autoimmune hepatitis in Japan-correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis. J. Hepatol. 1997; 26: 1207-1212.
11. Alvarez F, Berg PA, Bianchi FB etal. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J. Hepatol. 1999; 31: 929-938.
12. Munoz-Espinosa L, Alarcon G, Mercado-Moreira A etal. Performance of the international classifications criteria for autoimmune hepatitis diagnosis in Mexican patients. Autoimmunity 2011; 44: 543-548.
13. Yeoman AD, Westbrook RH, Al-Chalabi T etal. Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease. Hepatology 2009; 50: 538-545.
14. Czaja AJ. Performance parameters of the diagnostic scoring systems for autoimmune hepatitis. Hepatology 2008; 48: 1540-1548.
15. Hennes EM, Zeniya M, Czaja AJ etal. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008; 48: 169-176.
16. Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002; 36: 479-497.
17. Park BK, Park YN, Ahn SH etal. Long-term outcome of chronic hepatitis B based on histological grade and stage. J. Gastroenterol. Hepatol. 2007; 22: 383-388.
18. Boberg KM. Prevalence and epidemiology of autoimmune hepatitis. Clin. Liver Dis. 2002; 6: 635-647.
19. Manns MP, Czaja AJ, Gorham JD etal. Diagnosis and management of autoimmune hepatitis. Hepatology 2010; 51: 2193-2213.
20. Verslype C, George C, Buchel E, Nevens F, van Steenbergen W, Fevery J. Diagnosis and treatment of autoimmune hepatitis at age 65 and older. Aliment. Pharmacol. Ther. 2005; 21: 695-699.
21. McFarlane I. The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis. Gut 1998; 42: 599-602.
22. Manns MP, Strassburg CP. Autoimmune hepatitis: clinical challenges. Gastroenterology 2001; 120: 1502-1517.
23. Feld JJ, Dinh H, Arenovich T, Marcus VA, Wanless IR, Heathcote EJ. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology 2005; 42: 53-62.
24. Mieli-Vergani G, Vergani D. Autoimmune hepatitis. Nat. Rev. Gastroenterol. Hepatol. 2011; 8: 320-329.
25. McFarlane IG. Autoimmune hepatitis: diagnostic criteria, subclassifications, and clinical features. Clin. Liver Dis. 2002; 6: 605-621.
26. Abe M, Mashiba T, Zeniya M, Yamamoto K, Onji M, Tsubouchi H. Present status of autoimmune hepatitis in Japan: a nationwide survey. J. Gastroenterol. 2011; 46: 1136-1141.
27. Minuk GY, Liu S, Kaita K etal. Autoimmune hepatitis in a North American Aboriginal/First Nations population. Can. J. Gastroenterol. 2008; 22: 829-834.
28. Al-Chalabi T, Boccato S, Portmann BC, McFarlane IG, Heneghan MA. Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J. Hepatol. 2006; 45: 575-583.
29. Ahn SH, Han KH, Park JY etal. Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology 2000; 31: 1371-1373.
30. Krawitt EL. Autoimmune hepatitis. N. Engl. J. Med. 2006; 354: 54-66.
31. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Significance of HLA DR4 in type 1 autoimmune hepatitis. Gastroenterology 1993; 105: 1502-1507.
32. Muratori P, Granito A, Quarneti C etal. Autoimmune hepatitis in Italy: the Bologna experience. J. Hepatol. 2009; 50: 1210-1218.
33. Muratori P, Granito A, Pappas G, Muratori L. Validation of simplified diagnostic criteria for autoimmune hepatitis in Italian patients. Hepatology 2009; 49: 1782-1783; author reply 3.
34. Czaja AJ. Comparability of probable and definite autoimmune hepatitis by international diagnostic scoring criteria. Gastroenterology 2011; 140: 1472-1480.